Unbound MEDLINE

Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines. British journal of cancer [Br J Cancer] Journal article

 
TitlePoly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines.
Author(s)Zaremba T, Ketzer P, Cole M, Coulthard S, Plummer ER, Curtin NJ 
InstitutionNorthern Institute for Cancer Research, Newcastle University, Paul O'Gorman Building, Newcastle upon Tyne NE2 4HH, UK.
SourceBr J Cancer 2009 Jun 30.
AbstractBackground:Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA-binding enzyme activated by DNA breaks and involved in DNA repair and other cellular processes. Poly(ADP-ribose) polymerase activity can be higher in cancer than in adjacent normal tissue, but cancer predisposition is reported to be greater in individuals with a single-nucleotide polymorphism (SNP) V762A (T2444C) in the catalytic domain that reduces PARP-1 activity.
Methods:To resolve these divergent observations, we determined PARP-1 polymorphisms, PARP-1 protein expression and activity in a panel of 19 solid and haematological, adult and paediatric human cancer cell lines.
Results:There was a wide variation in PARP activity in the cell line panel (coefficient of variation, CV=103%), with the lowest and the highest activity being 2460 pmol PAR/10(6) (HS-5 cells) and 85 750 pmol PAR/10(6) (NGP cells). Lower variation (CV=32%) was observed in PARP-1 protein expression with the lowest expression being 2.0 ng mug(-1) (HS-5 cells) and the highest being 7.1 ng mug(-1) (ML-1 cells). The mean activity in the cancer cells was 45-fold higher than the mean activity in normal human lymphocytes and the PARP-1 protein levels were 23-fold higher.
Conclusions:Surprisingly, there was no significant correlation between PARP activity and PARP-1 protein level or the investigated polymorphisms, T2444C and CA.British Journal of Cancer advance online publication, 30 June 2009; doi:10.1038/sj.bjc.6605166 www.bjcancer.com.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19568233
  
Advertise on this site.